整合脐带血代谢物与临床指标提升新生儿缺氧缺血性脑病预测
本研究前瞻性纳入足月围产期窒息新生儿(伴或不伴HIE)及匹配对照,采集脐带血行代谢组学分析,用logistic回归和机器学习筛选特征。结论是联合临床与代谢数据可在出生后早期准确识别将发生HIE的婴儿,利于早期启动治疗性低温。
要点
- 脐带血代谢组学可预测足月儿HIE,单独代谢组AUC为0.67。
- 乳酸和丙氨酸是预测HIE的主要代谢物因子。
- 代谢物联合临床数据后预测HIE的AUC提高至0.96。
核心结论
- 联合临床与代谢数据可在出生后不久准确识别将发生HIE的婴儿,从而允许早期启动治疗性低温。
研究设计与样本
- 前瞻性研究纳入2个大型产科单位的足月围产期窒息新生儿(伴或不伴HIE)及匹配对照,于出生时采集脐带血行质谱代谢组学分析并记录临床资料。
- 采用logistic回归建模和机器学习技术筛选预测HIE的最佳临床与代谢物特征组合。
- HIE结局由临床Sarnat分级确定,并在24小时经脑电图分级确认。
主要发现
- 代谢组数据预测HIE发生的AUC为0.67(95%CI 0.62-0.71)。
- 乳酸和丙氨酸是预测HIE发生的主要代谢物因子。
- 代谢物联合临床数据预测HIE的AUC为0.96(95%CI 0.92-0.95)。
关键数值与推荐
- 代谢组数据单独预测HIE的AUC为0.67(95%CI 0.62-0.71)。
- 代谢物联合临床数据预测HIE的AUC为0.96(95%CI 0.92-0.95)。
临床怎么用
- 对足月围产期窒息新生儿,可考虑采集脐带血行代谢组学分析,结合临床数据早期评估HIE风险。
- 联合模型预测HIE风险高者,可尽早启动治疗性低温以争取治疗时间窗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To validate our previously identified candidate metabolites, and to assess the ability of these metabolites to predict hypoxic-ischemic encephalopathy (HIE) both individually and combined with clinical data. STUDY DESIGN: Term neonates with signs of perinatal asphyxia, with and without HIE, and matched controls were recruited prospectively at birth from 2 large maternity units. Umbilical cord blood was collected for later batch metabolomic analysis by mass spectroscopy along with clinical details. The optimum selection of clinical and metabolites features with the ability to predict the development of HIE was determined using logistic regression modelling and machine learning techniques. Outcome of HIE was determined by clinical Sarnat grading and confirmed by electroencephalogram grade at 24 hours. RESULTS: Fifteen of 27 candidate metabolites showed significant alteration in infants with perinatal asphyxia or HIE when compared with matched controls. Metabolomic data predicted the development of HIE with an area under the curve of 0.67 (95% CI, 0.62-0.71). Lactic acid and alanine were the primary metabolite predictors for the development of HIE, and when combined with clinical data, gave an area under the curve of 0.96 (95% CI, 0.92-0.95). CONCLUSIONS: By combining clinical and metabolic data, accurate identification of infants who will develop HIE is possible shortly after birth, allowing early initiation of therapeutic hypothermia.
引用
- O'Boyle DS, Dunn WB, O'Neill D, et al. Improvement in the Prediction of Neonatal Hypoxic-Ischemic Encephalopathy with the Integration of Umbilical Cord Metabolites and Current Clinical Makers. J Pediatr. 2020. PMID: 33039387. doi:10.1016/j.jpeds.2020.09.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。